You are here:
12 November 2021 / deal

EQT AB acquires Life Sciences Partners

Loyens & Loeff advised EQT Partners AB on the acquisition of Life Sciences Partners, a leading European life sciences venture capital firm.

EQT AB acquires Life Sciences Partners

EQT AB acquires Life Sciences Partners - a leading European life sciences venture capital firm with approximately EUR 2.2 billion of assets under management and a team of 34 professionals. Life Sciences Partners will strengthen EQT’s position as one of the leading and most active private markets investors in the healthcare sector.

Loyens & Loeff advised EQT on this acquisition, with a team led by Antoinette van der Hauw and supported by Gearte Sijens, Anna van der Donk, Konstantina Antoniou, Freek Hilberdink, Erwin Bosma, Louis Lutz, Sandrine Lekkerkerker, Anne Remmers, Wendy Pronk, Sebastiaan Hooghiemstra, Sebastiaan Verkerk, Klaas Wiersma and Florentine Deur.  



The Legal 500 Private Equity Country Comparative Guide 2021

The Legal 500 Private Equity Country Comparative Guide 2021

Loyens & Loeff has contributed to the publication of the 2021 edition. read more
Energy-green

Congratulations Pure Energie with 125MW in Windplan Groen

Congratulations to Pure Energie with the completion of the financing of three wind parks in Windplan Groen with a combined maximum capacity of 125 MW. read more
Summit Partners sells Viroclinics-DDL to Cerba Healthcare

Summit Partners sells Viroclinics-DDL to Cerba Healthcare

Loyens & Loeff assisted Summit Partners with the proposed sale of Viroclinics-DDL read more